Camp4 Therapeutics (CAMP) Operating Leases (2023 - 2026)

Camp4 Therapeutics' Operating Leases history runs 4 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Operating Leases fell 63.02% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 63.02% YoY), while the FY2025 annual figure was $1.7 million, down 69.27% from the prior year.
• Operating Leases came in at $1.7 million for Q1 2026 at Camp4 Therapeutics, up from $1.7 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $8.5 million in Q4 2023 to a low of $1.7 million in Q4 2025.
• A 4-year average of $4.8 million and a median of $5.1 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases plunged 35.28% in 2024 and plunged 69.27% in 2025, its largest moves.
• Camp4 Therapeutics' Operating Leases stood at $8.5 million in 2023, then tumbled by 35.28% to $5.5 million in 2024, then slumped by 69.27% to $1.7 million in 2025, then climbed by 2.96% to $1.7 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $1.7 million, $1.7 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison